Лучшие больницы для «Brain Tumor Surgery» в Хайдарабад, Индия

The cost of brain tumor surgery in India ranges from approximately $5,000 to $18,000 USD, making it one of the most cost-effective destinations globally for high-quality neurosurgical care. This range covers craniotomy with microsurgical resection, intraoperative neurophysiological monitoring, a 7–14 day hospital stay including ICU, standard postoperative medications, and molecular pathology reporting. Advanced add-ons such as intraoperative MRI (iMRI) or 5-ALA fluorescence guidance may add $1,000–$3,000 to the total. In the UAE (Dubai or Abu Dhabi), the same procedures cost between $12,000 and $40,000 USD—reflecting the premium infrastructure, luxury hospital environment, and higher operational costs in the Gulf. Both destinations charge significantly less than the United States ($80,000–$150,000) or the United Kingdom (£60,000–£100,000) for equivalent procedures. GAF Healthcare provides fully itemized cost estimates before travel so there are no hidden charges. Note that stereotactic radiosurgery (Gamma Knife or CyberKnife), if required as a standalone or adjuvant procedure, is priced separately at $4,000–$8,000 in India and $8,000–$18,000 in the UAE.

The minimum safe in-country stay after brain tumor surgery is typically 4–8 weeks, depending on the surgical complexity, your neurological recovery, and your destination (short-haul vs. long-haul flight). For the first 7–14 days, you will be in hospital recovering in the ICU and then the ward. After discharge, you will need to remain near the treating hospital for wound review, suture removal (Day 10–14), and a critical post-operative MRI at 2–4 weeks to assess resection extent and rule out early complications such as pseudo-progression, residual tumor, or hydrocephalus. Clearance for flight is given by your neurosurgeon based on three criteria: wound integrity, neurological stability, and absence of active venous thromboembolism (VTE) risk. Short-haul flights under 4 hours may be cleared as early as 3–4 weeks post-operatively for uncomplicated cases. Long-haul intercontinental flights—particularly those over 6–8 hours—require a minimum of 6–8 weeks post-operatively because prolonged immobility significantly increases DVT and pulmonary embolism risk, and cabin pressure changes can exacerbate cerebral edema in the early post-operative period. Patients who develop post-operative complications such as CSF leak, infection, or significant neurological deficit may require a longer in-country stay of up to 10–12 weeks. GAF Healthcare arranges comfortable serviced apartment accommodation for this recovery period.

Success rates in brain tumor surgery depend heavily on tumor type, WHO grade, molecular profile, location, and the extent of resection achieved. For benign tumors such as meningiomas (WHO Grade I), complete surgical resection (Simpson Grade I) is curative in over 90% of cases with a recurrence rate below 5% at 10 years. For vestibular schwannomas (acoustic neuromas), surgical resection or Gamma Knife radiosurgery achieves tumor control in 90–95% of cases. For WHO Grade II (low-grade gliomas, IDH-mutant), the 10-year overall survival exceeds 70% with maximum safe resection plus surveillance or adjuvant therapy. For glioblastoma (WHO Grade IV, IDH-wildtype)—the most aggressive primary brain tumor—the Stupp protocol (surgery + temozolomide + radiotherapy) yields a median overall survival of 14–16 months, with MGMT promoter-methylated patients achieving 21–24 months median survival; approximately 10–15% of patients survive beyond 5 years, and this subset is disproportionately represented among patients receiving molecular-guided therapy at high-volume centers. For single brain metastases, surgical resection combined with stereotactic radiosurgery (SRS) achieves local control in 85–95% of cases and significantly improves quality of life and survival over whole-brain radiotherapy alone. It is important to note that 'success' in neuro-oncology encompasses not only tumor control but also preservation of neurological function and quality of life—outcomes that are maximized by the high-volume, technology-equipped surgical teams available through GAF Healthcare's partner hospitals in India and the UAE.